PHARMA-BIO SERV, INC. Cash and Cash Equivalents
PHARMA-BIO SERV, INC. (PBSV) had Cash and Cash Equivalents of $2.87 million as of 2023-07-31, per its 10-Q filed 2023-09-14.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2023-09-14
- 2023-07-31: Cash and Cash Equivalents, at Carrying Value $2.87M.
- 2023-04-30: Cash and Cash Equivalents, at Carrying Value $8.10M.
- 2022-10-31: Cash and Cash Equivalents, at Carrying Value $14.46M.
- 2022-07-31: Cash and Cash Equivalents, at Carrying Value $14.24M.
| Period end | Cash and Cash Equivalents, at Carrying Value | Cash and Cash Equivalents, at Carrying Value as first filed |
|---|---|---|
| 2023-07-31 | $2.87M 10-Q · filed 2023-09-14 | |
| 2023-04-30 | $8.10M 10-Q · filed 2023-06-14 | |
| 2022-10-31 | $14.46M 10-Q · filed 2023-09-14 | |
| 2022-07-31 | $14.24M 10-Q · filed 2022-09-14 | |
| 2022-04-30 | $13.16M 10-Q · filed 2022-06-14 | |
| 2022-01-31 | $15.35M 10-Q · filed 2022-03-17 | |
| 2021-10-31 | $17.47M 10-K · filed 2023-01-30 | |
| 2021-07-31 | $16.50M 10-Q · filed 2021-09-14 | |
| 2021-04-30 | $16.07M 10-Q · filed 2021-09-14 | |
| 2021-01-31 | $18.99M 10-Q · filed 2021-06-14 | |
| 2020-10-31 | $17.14M 10-K · filed 2022-02-11 | |
| 2020-07-31 | $16.81M 10-Q · filed 2021-09-14 | |
| 2020-04-30 | $15.58M 10-Q · filed 2021-09-14 | |
| 2020-01-31 | $15.25M 10-Q · filed 2021-06-14 | |
| 2019-10-31 | $15.49M 10-K · filed 2022-02-11 | |
| 2019-07-31 | $14.80M 10-Q · filed 2020-09-14 | |
| 2019-04-30 | $15.43M 10-Q · filed 2020-09-14 | |
| 2019-01-31 | $15.80M 10-Q · filed 2020-06-15 | |
| 2018-10-31 | $16.03M 10-K · filed 2021-02-01 | |
| 2018-07-31 | $15.12M 10-Q · filed 2019-09-16 | $15.19M 10-Q · filed 2018-09-14 |
| 2018-04-30 | $12.92M 10-Q · filed 2019-09-16 | $12.99M 10-Q · filed 2018-06-14 |
| 2018-01-31 | $13.07M 10-Q · filed 2019-06-14 | $13.18M 10-Q · filed 2018-03-19 |
| 2017-10-31 | $11.59M 10-K · filed 2020-01-29 | $11.75M 10-K · filed 2018-01-29 |
| 2017-07-31 | $12.20M 10-Q · filed 2018-09-14 | |
| 2017-04-30 | $12.71M 10-Q · filed 2018-09-14 | |
| 2017-01-31 | $13.67M 10-Q · filed 2018-06-14 | |
| 2016-10-31 | $13.77M 10-K · filed 2019-01-29 | |
| 2016-07-31 | $14.01M 10-Q · filed 2017-09-14 | |
| 2016-04-30 | $14.43M 10-Q · filed 2017-09-14 | |
| 2016-01-31 | $14.52M 10-Q · filed 2017-06-14 | |
| 2015-10-31 | $14.89M 10-K · filed 2018-01-29 | |
| 2015-07-31 | $14.01M 10-Q · filed 2016-09-14 | |
| 2015-04-30 | $14.41M 10-Q · filed 2016-09-14 | |
| 2015-01-31 | $15.15M 10-Q · filed 2016-06-14 | $15.05M 10-Q · filed 2015-03-17 |
| 2014-10-31 | $15.09M 10-K · filed 2017-01-31 | |
| 2014-07-31 | $13.80M 10-Q · filed 2015-09-14 | |
| 2014-04-30 | $12.83M 10-Q · filed 2015-09-14 | |
| 2014-01-31 | $13.78M 10-Q · filed 2015-06-15 | |
| 2013-10-31 | $12.05M 10-K · filed 2016-01-29 | |
| 2013-07-31 | $9.10M 10-Q · filed 2014-09-15 | |
| 2013-04-30 | $8.49M 10-Q · filed 2014-09-15 | |
| 2013-01-31 | $7.01M 10-Q · filed 2014-06-16 | |
| 2012-10-31 | $6.54M 10-K · filed 2015-01-29 | |
| 2012-07-31 | $5.03M 10-Q · filed 2013-09-16 | |
| 2012-04-30 | $3.98M 10-Q · filed 2013-09-16 | |
| 2012-01-31 | $4.17M 10-Q · filed 2013-06-14 | |
| 2011-10-31 | $4.32M 10-K · filed 2014-01-29 | |
| 2011-07-31 | $3.59M 10-Q · filed 2012-09-14 | |
| 2011-04-30 | $2.55M 10-Q · filed 2012-09-14 | |
| 2011-01-31 | $2.41M 10-Q · filed 2012-06-14 | |
| 2010-10-31 | $2.32M 10-K · filed 2013-01-29 | |
| 2010-07-31 | $1.93M 10-Q · filed 2011-09-14 | |
| 2010-04-30 | $2.55M 10-Q · filed 2011-09-14 | |
| 2009-10-31 | $2.05M 10-K/A · filed 2012-01-31 |